CheckMyRecalls

Leading Pharma, LLC recalls Furosemide Tablets

Published
29 Apr 2026
Units affected
9384 bottles
Agency
FDA
Country
United States

The hazard

CGMP Deviations; presence of N-nitroso-Furosemide (NNF) above the recommended intake limit.

Classification: Class II — this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Furosemide Tablets, USP, 80 mg, 100 Tablets bottles, Rx only, Manufactured by: Leading Pharma, LLC, Fairfield, NJ 07004, NDC 69315-118-01

Brand / company
Leading Pharma, LLC
Codes / lots
Lots# H03125, H03225, H03325, Exp Date: 2027/08
Distribution
US Nationwide.
Recall status
Ongoing

Source: U.S. Food and Drug Administration, published 29 Apr 2026. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.